Ignite Creation Date:
2024-05-06 @ 1:16 PM
Last Modification Date:
2024-10-26 @ 1:11 PM
Study NCT ID:
NCT03971669
Status:
RECRUITING
Last Update Posted:
2024-02-23
First Post:
2019-05-29
Brief Title:
Blood Donor CVD 5000
Sponsor:
University of Maryland Baltimore
Organization:
University of Maryland Baltimore
Study Overview
Official Title:
Collection of Blood Samples for In-Vitro Studies From Healthy Adult Blood Donors Who Have Received Oral Typhoid Vaccine TY21A
Status:
RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is an open-label non-randomized study Volunteers will be vaccinated with the typhoid oral vaccine Vivotif Vivotif has been licensed by the Food and Drug Administration FDA for travelers to developing countries Volunteers will also be asked to provide blood saliva and stool specimens over a follow-up time period of up to eight years The specimens obtained in this clinical research study will be used to further the investigators understanding of the protective immunological mechanisms that can be elicited systemically and may be applicable to other enteric pathogens
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None